Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders

PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders

US Patent 7297715 · Granted Nov 20, 2007

Estimated economic value: $107,484,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted oxazolidinones for the treatment of mammalian infections2024
Process for the preparation of quinolone based compounds2021
Short-chain peptides as Kappa (κ) opioid receptors (KOR) agonist2020
Heterocyclic compounds2019
Heterocyclic compounds2018
Heterocyclic compounds2017
Substituted phthalazin-1 (2H)-one derivatives as selective inhibitors of poly (A2017
N-cyanomethylamides as inhibitors of janus kinase2017
Quinolone derivatives2016
Tris(hydroxymethyl)aminomethane salts of a small-molecule GLP1R agonist and phar2015
Efficient production of heterologous proteins using mannosyl transferase inhibit2014
P38 kinase inhibiting agents2013